The invention provides a compound of formula (I): T is C(O) or S(O).sub.2; W is CH.sub.2, (CH.sub.2).sub.2, CH(CH.sub.3), CH(CH.sub.3)O or cyclopropyl; X is O, CH.sub.2, C(O), S, S(O), S(O).sub.2 or NR.sup.3; m is 0 or 1; R.sup.1 is optionally substituted aryl or optionally substituted heterocyclyl; R.sup.2 is alkyl (optionally substituted by OH), cycloalkyl, optionally substituted aryl or optionally substituted heterocyclyl; that are modulators of chemokine (especially CCR3) activity and are especially useful for treating asthma and/or rhinitis.